RELATIONSHIP BETWEEN MOLECULAR-STRUCTURE AND CYTOCHROME-P450 METABOLIC INTERMEDIATE COMPLEX-FORMATION, STUDIED WITH ORPHENADRINE ANALOGS

被引：16

作者：

BAST, A

SAVENIJECHAPEL, EM

NOORDHOEK, J

机构：

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1984年 / 73卷 / 07期

关键词：

D O I：

10.1002/jps.2600730723

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：953 / 956

页数：4

相关论文

共 24 条

[1] ROLE OF SUBSTRATE LIPOPHILICITY IN DETERMINING TYPE-1 MICROSOMAL P450 BINDING CHARACTERISTICS
ALGAILANY, KAS
HOUSTON, JB
BRIDGES, JW
[J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (05) : 783 - 788
[2] BAST A, 1983, RES COMMUN CHEM PATH, V40, P391
[3] SPECTRAL INTERACTION OF ORPHENADRINE AND ITS METABOLITES WITH OXIDIZED AND REDUCED HEPATIC-MICROSOMAL CYTOCHROME-P-450 IN THE RAT
BAST, A
NOORDHOEK, J
[J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (17) : 2745 - 2753
[4] CALCULATION OF COMPETITIVE-INHIBITION OF SUBSTRATE BINDING TO CYTOCHROME-P-450 ILLUSTRATED BY THE INTERACTION OF D,L-PROPRANOLOL WITH D,L-HEXOBARBITAL
BAST, A
NOORDHOEK, J
[J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (05) : 747 - 751
[5] BUENING MK, 1974, DRUG METAB DISPOS, V2, P386
[6] DANAN G, 1981, J PHARMACOL EXP THER, V218, P509
[7] DELAFORGE M, 1982, 8TH EUR WORKSH DRUG, P83
[8] Estabrook RW., 1972, METHODS PHARM, Vvol 2, P303
[9] INHIBITION OF MIXED-FUNCTION OXIDATIONS BY SUBSTRATES FORMING REDUCED CYTOCHROME-P-450 METABOLIC-INTERMEDIATE COMPLEXES
FRANKLIN, MR
[J]. PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1977, 2 (01): : 227 - 245
[10] INHIBITION OF METABOLISM OF N-SUBSTITUTED AMPHETAMINES BY SKF 525-A AND RELATED COMPOUNDS
FRANKLIN, MR
[J]. XENOBIOTICA, 1974, 4 (03) : 143 - 150